Literature DB >> 26870266

Downregulation of Pygopus 2 inhibits vascular mimicry in glioma U251 cells by suppressing the canonical Wnt signaling pathway.

Haidong Wang1, Jianhua Fu2, Dianshuang Xu1, Weiwei Xu1, Shiyong Wang1, Liu Zhang1, Yongsheng Xiang1.   

Abstract

Gliomas are the most common type of malignant primary brain tumor, and the Wnt signaling pathway is associated with glioma malignancy. Pygopus protein plays an important role in developmental brain patterning, and has been identified to be a component of the Wnt signaling pathway. In the present study, the Pygopus 2 (Pygo2) protein was examined in 80 glioma tissue samples. Short hairpin (sh)RNA-Pygo2 was transfected into glioma U251 cells, and the cell proliferation, colony formation and bromodeoxyuridine (BrdU) incorporation were analyzed. Western blot analysis and reverse transcription-polymerase chain reaction were used to detect the expression of Pygo2. A vascular mimicry assay was performed to examine the vascular mimicry of U251 cells. A luciferase reporter assay was used to detect the β-catenin/Wnt system. The cyclin D1 protein was also detected using western blot analysis. The results demonstrated that inhibition of the expression of Pygo2 significantly triggered the decrease of cell proliferation, colony formation and BrdU incorporation compared with the cells treated with scramble control shRNA (shRNA-Scr). shRNA-Pygo2 transfection was found to inhibit vascular-mimicry and block the Wnt signaling pathway compared to the cells transfected with shRNA-Scr. The transfection of shRNA-Pygo2 also decreased the expression of the Wnt target gene cyclin D1. In conclusion, shRNA-Pygo2 suppressed glioma cell proliferation effectively and inhibited vascular mimicry by inhibiting the expression of cyclin D1 in the canonical Wnt/β-catenin pathway in brain glioma cells.

Entities:  

Keywords:  Pygopus 2; Wnt signaling pathway; cyclin D1; glioma; proliferation

Year:  2015        PMID: 26870266      PMCID: PMC4727031          DOI: 10.3892/ol.2015.3917

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  31 in total

Review 1.  Wnt signaling and cancer.

Authors:  P Polakis
Journal:  Genes Dev       Date:  2000-08-01       Impact factor: 11.361

2.  Wnt/wingless signaling requires BCL9/legless-mediated recruitment of pygopus to the nuclear beta-catenin-TCF complex.

Authors:  Thomas Kramps; Oliver Peter; Erich Brunner; Denise Nellen; Barbara Froesch; Sandipan Chatterjee; Maximilien Murone; Stephanie Züllig; Konrad Basler
Journal:  Cell       Date:  2002-04-05       Impact factor: 41.582

Review 3.  Wnt, stem cells and cancer in the intestine.

Authors:  Daniel Pinto; Hans Clevers
Journal:  Biol Cell       Date:  2005-03       Impact factor: 4.458

4.  Requirement of Pygopus 2 in breast cancer.

Authors:  Phillip G P Andrews; Blue B Lake; Catherine Popadiuk; Kenneth R Kao
Journal:  Int J Oncol       Date:  2007-02       Impact factor: 5.650

5.  Glioblastoma multiforme: Molecular characterization and current treatment strategy (Review).

Authors:  Xiang Zhang; Wei Zhang; Wei-Dong Cao; Gang Cheng; Yong-Qiang Zhang
Journal:  Exp Ther Med       Date:  2011-10-18       Impact factor: 2.447

6.  MicroRNA218 inhibits glioma migration and invasion via inhibiting glioma-associated oncogene homolog 1 expression at N terminus.

Authors:  Biao Peng; Dan Li; Mingjun Qin; Dongdong Luo; Xun Zhang; Hailin Zhao; Su Hu
Journal:  Tumour Biol       Date:  2013-12-21

Review 7.  The Wnt signaling pathway and its role in tumor development.

Authors:  B Lustig; J Behrens
Journal:  J Cancer Res Clin Oncol       Date:  2003-04-18       Impact factor: 4.553

8.  Antisense suppression of pygopus2 results in growth arrest of epithelial ovarian cancer.

Authors:  Cathy M Popadiuk; Jieying Xiong; Malcolm G Wells; Phillip G Andrews; Kweku Dankwa; Kensuke Hirasawa; Blue B Lake; Kenneth R Kao
Journal:  Clin Cancer Res       Date:  2006-04-01       Impact factor: 12.531

9.  Developmental phenotypes and reduced Wnt signaling in mice deficient for pygopus 2.

Authors:  Boan Li; Catherine Rhéaume; Andy Teng; Virginia Bilanchone; Jesus E Munguia; Ming Hu; Shannon Jessen; Stefano Piccolo; Marian L Waterman; Xing Dai
Journal:  Genesis       Date:  2007-05       Impact factor: 2.487

10.  microRNA-124 inhibits migration and invasion by down-regulating ROCK1 in glioma.

Authors:  Liwen An; Yongjun Liu; Anhua Wu; Yifu Guan
Journal:  PLoS One       Date:  2013-07-23       Impact factor: 3.240

View more
  3 in total

Review 1.  Vascular mimicry: changing the therapeutic paradigms in cancer.

Authors:  Nazila Fathi Maroufi; Sina Taefehshokr; Mohammad-Reza Rashidi; Nima Taefehshokr; Mahdieh Khoshakhlagh; Alireza Isazadeh; Narmin Mokarizadeh; Behzad Baradaran; Mohammad Nouri
Journal:  Mol Biol Rep       Date:  2020-05-18       Impact factor: 2.316

2.  Wnt/β-catenin signaling pathway inhibits the proliferation and apoptosis of U87 glioma cells via different mechanisms.

Authors:  Liyang Gao; Bing Chen; Jinhong Li; Fan Yang; Xuecheng Cen; Zhuangbing Liao; Xiao'ao Long
Journal:  PLoS One       Date:  2017-08-24       Impact factor: 3.240

Review 3.  Mechanisms of Vasculogenic Mimicry in Ovarian Cancer.

Authors:  Lízbeth Ayala-Domínguez; Leslie Olmedo-Nieva; J Omar Muñoz-Bello; Adriana Contreras-Paredes; Joaquín Manzo-Merino; Imelda Martínez-Ramírez; Marcela Lizano
Journal:  Front Oncol       Date:  2019-09-27       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.